Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Porphyromonas Gingivalis Elimination From Oral Improves Esophageal Cancer Patients Survival After Radical Operation

NCT06418945 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Henan University of Science and Technology as lead sponsor.

NCT NCT06418945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06418945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Porphyromonas Gingivalis Elimination From Oral Improves Esophageal Cancer Patients Survival After Radical Operation
Lead sponsor
The First Affiliated Hospital of Henan University of Science and Technology
Phase
Phase 3
Overall status
Not yet recruiting
Start date
August 1, 2024
Completion date
December 31, 2027
Enrollment
500 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

evaluate the dfs of patients with esophageal cancer who underwent radical operation after regular removal of porphyromonas gingivalis